Literature DB >> 1968170

Prophylactic intraventricular pumping in high-risk coronary angioplasty.

D Loisance1, J L Dubois-Randé, P Deleuze, J Okude, O Rosenval, H Geschwind.   

Abstract

The 'Hemopump', an axial flow pump, when inserted in the left ventricle brings about mechanical unloading of the ventricle, thus reducing the risk of cardiac arrest during coronary angioplasty. In this study eight very ill patients with unstable myocardial ischaemia and various contraindications for coronary artery surgery were selected for coronary angioplasty with insertion of the hemopump. Anatomical difficulties prevented insertion in three patients, but coronary angioplasty was carried out successfully with the pump in place in the other five. When the pump was working the cardiac index rose by an average of 23% (8-50%) and the pulmonary capillary wedge pressure fell by 17% (0-22%). Though electrocardiographic monitoring showed temporary rhythm instability during angioplasty in four of the five patients, there was no clinical deterioration. Four of the five patients are symptom-free on medical treatment and the other is well after surgical revascularisation.

Entities:  

Mesh:

Year:  1990        PMID: 1968170     DOI: 10.1016/0140-6736(90)90666-s

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  3 in total

1.  Integrated unit for programmable control of the 21F Hemopump and registration of physiological signals.

Authors:  E E Kunst; J A van Alsté; T Arts; H B Boom
Journal:  Med Biol Eng Comput       Date:  1994-11       Impact factor: 2.602

2.  Peripheral organ perfusion augmentation during left ventricular failure. A controlled bovine comparison between the intraaortic balloon pump and the Hemopump.

Authors:  R T Baldwin; B Radovancević; J L Conger; R Matsuwaka; J M Duncan; W K Vaughn; R K Wampler; O H Frazier
Journal:  Tex Heart Inst J       Date:  1993

3.  Percutaneous Hemodynamic Support in PCI.

Authors:  Jason Hatch; Dmitri Baklanov
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.